Document is current
Any future updates will be listed below
-
Authors
Dayoub, Adam S.
Brekken, Rolf A. https://orcid.org/0000-0003-2704-2377
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA192381, CA210181)
Oncologie (NA)
- License Information
-
More Information
Article History
Received: 22 October 2019
Accepted: 29 January 2020
First Online: 22 February 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: RAB receives research support from Oncologie, which is driving the clinical development of PS-targeting mAbs.
